
Curaleaf Holdings has launched a formal takeover bid for Aurora Cannabis, offering $4.00 per share, which includes cash and Curaleaf shares, representing a 45% premium over Aurora's unaffected share price. The offer aims to create a global cannabis leader by combining Curaleaf's scale and resources with Aurora's cultivation and genetics capabilities. Curaleaf highlights significant benefits for Aurora shareholders, including immediate value, exposure to the U.S. cannabis market, and potential cost synergies. The offer is open until December 1, 2026, and Curaleaf remains open to constructive discussions with Aurora's board despite previous rejections.